» Journals » Saudi Pharm J

Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society

The Saudi Pharmaceutical Journal (SPJ) is the official publication of the Saudi Pharmaceutical Society. It is a peer-reviewed journal that focuses on pharmaceutical research, education, and practice in Saudi Arabia and the wider Middle East region. SPJ publishes original articles, reviews, and case studies related to various aspects of pharmaceutical sciences, including drug discovery, formulation, pharmacology, and clinical pharmacy. The journal serves as a platform for researchers, practitioners, and educators to share their knowledge and contribute to the advancement of pharmaceutical scien

Details
Abbr. Saudi Pharm J
Start 1993
End Continuing
Frequency Quarterly, 1994-
p-ISSN 1319-0164
e-ISSN 2213-7475
Country Saudi Arabia
Language English
Specialty Pharmacy
Metrics
h-index / Ranks: 4647 76
SJR / Ranks: 7539 598
CiteScore / Ranks: 2534 7.50
JIF / Ranks: 2178 4.1
Recent Articles
31.
Tobaiqy M, Al-Asmari A
Saudi Pharm J . 2024 Sep; 32(10):102163. PMID: 39262681
Introduction: This review examines substance misuse disorder (SMD) in Saudi Arabia, drawing insights from 43 prior studies. It explores the prevalence and patterns of SMD across diverse demographics. Methodology: Our...
32.
Yao Y, Zhao Q, Xu F, Yao T
Saudi Pharm J . 2024 Aug; 32(9):102153. PMID: 39211513
Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. Sorafenib (Sf) is currently the first-line treatment for HCC. However, due to the side effects and unsatisfied efficiency of...
33.
Elsewedy H, Alshehri S, Alsammak N, Abou Chahin N, Alotaibi M, Alshammari R, et al.
Saudi Pharm J . 2024 Aug; 32(9):102152. PMID: 39165579
Skin infections considered as one of the predominant disorders that could greatly influence humans. Topical drug delivery is believed to be an effective substitute to systemically delivered medication for skin...
34.
Aljuffali L, Faihan BinLebdah A, Alfaraj R, Alkhelb D, Alsabhan J, Alanazi A, et al.
Saudi Pharm J . 2024 Aug; 32(9):102151. PMID: 39161743
This study explores the course review process implemented by the College of Pharmacy at King Saud University for its Pharm.D. program. Through a qualitative research design, a dedicated course review...
35.
Alasmari A, Alshehri M, Ali N, Alasmari F, Sari Y, Childers W, et al.
Saudi Pharm J . 2024 Aug; 32(9):102148. PMID: 39157423
Drug addiction is considered a worldwide concern and one of the most prevailing causes of death globally. Opioids are highly addictive drugs, and one of the most common opioids that...
36.
Gao K, Chen Z, Zhang N, Jiang P
Saudi Pharm J . 2024 Aug; 32(9):102139. PMID: 39139718
Lung cancer ranks as the 2nd most common cancer globally. It's the most prevalent cancer in men and the 2nd most common in women. The prominent events in EGFR-mutated non-small-cell...
37.
Alameen A, AlSharari S, Alshammari M, Damaj M, Sari Y
Saudi Pharm J . 2024 Aug; 32(8):102138. PMID: 39109164
Background: The recent global increase in obesity rates, coupled with excessive palatable food (PF) consumption, has become a serious societal concern. Literature indicates that rewarding PF, especially upon cessation, can...
38.
Cakmak D, Bektay M, Al-Taie A, Jadoo S, Izzettin F
Saudi Pharm J . 2024 Aug; 32(8):102140. PMID: 39109163
Background: Asthma, a chronic respiratory disease, is effectively managed with medications, yet many patients struggle due to irregular treatment and poor adherence. Pharmacists play a crucial role in improving asthma...
39.
Alghamdi S, Ghosh Dastidar R, Rybinski M, Alsufiani H, Khoja S, Enaibsi N, et al.
Saudi Pharm J . 2024 Jul; 32(8):102137. PMID: 39040871
The concept of the vitamin D response index was developed based on vitamin D intervention studies conducted with Finnish cohorts. In this study, we challenged the concept by performing a...
40.
Almusallam N, Alonazi A, Bin Dayel A, Almubarak A, Ali R, Althakfi W, et al.
Saudi Pharm J . 2024 Jul; 32(7):102102. PMID: 39035363
Post-acute myocardial infarction (AMI) fibrosis is a pathophysiologic process characterised by activation of the profibrotic mediator, transforming growth factor-β (TGF-β). AMI is associated with a substantial increase in the levels...